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iTATE-OF-THE-ART PAPER1613The Clinical Significance of CAC Progressionohn W. McEvoy, Michael J. Blaha, Andrew P. DeFilippis, Matthew J. Budoff, Khurram Nasir,
oger S. Blumenthal, Steven R. Jones
erial assessment of coronary artery calcification (CAC) has been proposed for monitoring
therosclerosis progression and for assessing the effectiveness of medical therapies aimed at
educing cardiac risk. McEvoy and colleagues conducted a comprehensive review of the
iterature on CAC progression. CAC progression correlates well with worsening
therosclerosis and future cardiac events. However, trials have shown that interventions
uch as statins, which are known to be beneficial, have not slowed the progression of
AC. Before serial quantification of CAC can be routinely recommended, standards of
efining CAC progression need to be developed and the interaction between effective
herapies and CAC must be analyzed further.CLINICAL RESEARCH NTERVENTIONAL CARDIOLOGY1623Anatomic and Procedural Predictors of Paravalvular AR After TAVIohammad A. Sherif, Mohamed Abdel-Wahab, Björn Stöcker, Volker Geist, Doreen Richardt,
alph Tölg, Gert Richardt
herif and colleagues reviewed 50 patients who underwent transcatheter aortic valve
mplantation (TAVI) to determine the predictors of post-procedure aortic regurgitation (AR).
ngiographic grading of AR revealed no AR in 6%, grade I in 54%, grade II in 26%, and
rade III in 14% of patients. The risk of AR grade II or higher increased with a higher left
entricular outflow tract (LVOT)-to-ascending aorta angle and was lowest when the depth of
he device in relation to the noncoronary cusp was 9.5 mm. These results may help to
dentify suitable patients and guide operators during the procedure.(continued on page A-24)
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cNTIPLATELET THERAPY1630Clopidogrel Loading Dose Adjustment According to Platelet Reactivity Testingaurent Bonello, Sébastien Armero, Omar Ait Mokhtar, Julien Mancini, Philippe Aldebert, Noémie Saut,
athalie Bonello, Paul Barragan, Stéphane Arques, Marie-Paule Giacomoni, Caroline Bonello-Burignat,
arie-Noelle Bartholomei, Françoise Dignat-George, Laurence Camoin-Jau, Franck Paganelli
onello and colleagues investigated the effect of repeating the clopidogrel loading dose (LD)
or subjects with high platelet reactivity (PR). High on-treatment platelet reactivity (HTPR)
as defined as 50% with vasodilator-stimulated phosphoprotein index. Patients with
TPR had a first 600-mg LD of clopidogrel and another LD the following day, and then
R was reassessed, with up to 3 additional LDs allowed. All subjects were genotyped for the
ytochrome (CYP) 2C19*2 loss-of function polymorphism. Among the subjects with at least 1
utant allele and HTPR following the first clopidogrel LD, 88% reached a PR 50% using
p to 3 additional 600-mg LDs of clopidogrel.ditorial Comment: Stephen D. Wiviott, Jessica L. Mega, p. 1637NTIPLATELET THERAPY1639Clopidogrel May Improve Early Graft Patency After CABGe Gao, Zhe Zheng, Yi Pi, Bin Lu, Jinguo Lu, Shengshou Hu
revious studies have found that approximately 15% of saphenous vein grafts (SVGs) occlude
uring the first 3 months after coronary artery bypass grafting (CABG). Gao and colleagues
andomized 249 consecutive patients undergoing CABG to either aspirin or aspirin plus
lopidogrel, started as soon as chest tube drainage was 30 cc/h. Three months post-
peratively, subjects underwent 64-slice multislice computed tomography angiography.
total of 8.4% of grafts were occluded in the clopidogrel group compared with 14.3% in
he aspirin-only group. Aspirin plus clopidogrel is more effective for maintaining venous graft
atency after CABG than aspirin alone.EART FAILURE
1644ow Rate of Guideline-Based Therapy for LV Dysfunction
Due to Cardiotoxic Chemotherapy Agents0
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teoffrey J. Yoon, Melinda L. Telli, David P. Kao, Kelly Y. Matsuda, Robert W. Carlson, Ronald M. Witteles
atients treated with anthracyclines or trastuzumab (Herceptin, Genentech, South San
rancisco, California) are at risk for cardiotoxicity. Yoon and colleagues identified subjects
eceiving 1 or both of these medications who had serial echocardiograms at their institution.
orty percent of subjects who had pre- and post-treatment echocardiograms had decreased
eft ventricular ejection fraction (LVEF) (55%). Of these patients, 40% received
ngiotensin-converting enzyme inhibitor (ACEI) or angiotensin receptor blocker (ARB)
herapy, 51% beta-blocker therapy, and 54% cardiology consultation, with higher rates for
ymptomatic compared with asymptomatic subjects. The American College of Cardiology/
merican Heart Association guidelines recommend that all of these patients be treated with
CEI/ARB and a beta-blocker, suggesting that cancer patients are not receiving treatment
onsistent with heart failure guidelines.
(continued on page A-28)
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EEART RHYTHM DISORDERS1651Incidence and Predictors of Acute Lead Dislodgement After ICD Implant0.00
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Physician Implant Volumes by Quartiles
p<0.004 lan Cheng, Yongfei Wang, Jeptha P. Curtis, Paul D. Varosy
heng and colleagues reviewed data from the National Cardiovascular Data Registry
mplantable Cardioverter Defibrillator Registry to describe the incidence of acute lead
islodgements after implantable cardioverter-defibrillator (ICD) implants. Acute lead
islodgement was defined as movement of the lead requiring another procedure prior to
ischarge and occurred in 1.2% of patients. After multivariate adjustment, factors associated
ith an increased risk for dislodgement included New York Heart Association functional
lass IV heart failure, atrial fibrillation/flutter, having a cardiac resynchronization therapy-
efibrillator device, and having a procedure performed by nonelectrophysiology trained
mplanters. Dislodgements were associated with increased risk for other adverse events
ncluding cardiac arrest, cardiac tamponade, device infection, pneumothorax, and in-hospital
eath.ARDIAC IMAGING1657MRI to Noninvasively Assess Coronary Artery Endothelial Functionllison G. Hays, Glenn A. Hirsch, Sebastian Kelle, Gary Gerstenblith, Robert G. Weiss, Matthias Stuber
ays and colleagues studied the ability of magnetic resonance imaging (MRI) to measure
oronary endothelial function. Cross-sectional coronary area and blood flow were quantified
efore and during isometric handgrip exercise, an endothelial-dependent stressor. In healthy
dults, coronary arteries dilated and flow increased with handgrip, while both decreased in
oronary artery disease (CAD) patients. In patients with CAD, coronary artery area and
lood flow failed to increase during exercise in the mildly-diseased vessel, but both decreased
ignificantly in the severely-diseased artery. Endothelial-dependent coronary artery dilation
nd blood flow can be directly visualized and quantified noninvasively with MRI.ditorial Comment: Francis J. Klocke, p. 1666ARDIAC SURGERY
1668ait Speed Predicts Mortality and Major Morbidity
in Elderly Patients Undergoing Cardiac Surgery5.9%
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tyonathan Afilalo, Mark J. Eisenberg, Jean-François Morin, Howard Bergman, Johanne Monette,
icolas Noiseux, Louis P. Perrault, Karen P. Alexander, Yves Langlois, Nandini Dendukuri,
atrick Chamoun, Georges Kasparian, Sophie Robichaud, S. Michael Gharacholou, Jean-François Boivin
lderly patients may suffer from subclinical impairments in multiple inter-related systems that
esult in frailty, but are not identified in traditional risk prediction algorithms. Afilalo and
olleagues tested the value of slow gait speed, a measure of frailty, to predict mortality and
ajor morbidity in elderly patients undergoing cardiac surgery. Slow gait speed, defined as a
ime of 6 s taken to walk 5 m, was an independent predictor of the composite end point
fter adjusting for the Society of Thoracic Surgeons (STS) risk score. Gait speed is a simple
nd effective test that may identify a subset of elderly patients at higher risk after cardiac
urgery.ditorial Comment: Joseph C. Cleveland, p. 1677
